AREG and ovarian carcinoma: In survival study, Kaplan–Meier survival analysis of 518 cases from the Oncomine data showed that ovarian cancer patients with high AREG expression correlated with a significantly shorter survival than those with low AREG expression (P=0.0003, Figure 7b).